MARS2 and Autosomal recessive spastic ataxia with leukoencephalopathy: To explore the impact of the mutations on protein levels, control and ARSAL patient protein extracts were analyzed by immunoblotting with a mouse polyclonal antibody against the N-terminal end of human MARS2.